Skip to main content

Table 2 Baseline demographic characteristics of study participants stratified by Log10 copy-years/mL

From: Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana

Characteristics

Less than 2 AUVLC(Log10 copy-years/mL) (N = 51)

Between 2 and 4 AUVLC(Log10 copy-years/mL) (N = 27)

Greater than 4 AUVLC(Log10 copy-years/mL) (N = 62)

P value*

Age

4.6 (2.9, 51)a

4.1 (3.0, 27)

5.4 (3.1, 62)

0.1327

HIV status of father

   

0.4012

Yes

14 (73.7)b

1 (33.3)

19 (65.5)

 

No

5 (26.3)

2 (66.7)

10 (34.5)

 

HIV status of mother

   

0.5237

Yes

36 (97.3)

18 (100.0)

39 (92.9)

 

No

1 (2.7)

0 (0.0)

3 (7.1)

 

Gender

   

0.2792

Female

16 (31.4)

13 (48.1)

27 (43.5)

 

Male

35 (68.6)

14 (51.9)

35 (56.5)

 

Care Giver

   

0.4816

Aunt

4 (7.8)

2 (7.4)

8 (12.9)

 

Father

3 (5.9)

5 (18.5)

4 (6.5)

 

Grandmother

4 (7.8)

3 (11.1)

11 (17.7)

 

Mother

36 (70.6)

17 (63.0)

34 (54.8)

 

Stepmother

1 (2.0)

0 (0.0)

2 (3.2)

 

Uncle

3 (5.9)

0 (0.0)

3 (4.8)

 

WHO clinical Stage

   

0.9904

Stage I

6 (21.4)

2 (13.3)

6 (14.6)

 

Stage II

6 (21.4)

4 (26.7)

9 (22.0)

 

Stage III

10 (35.7)

6 (40.0)

17 (41.5)

 

Stage IV

6 (21.4)

3 (20.0)

9 (22.0)

 
  1. *The p value was generated using Wilcoxon Rank Sum test and Fisher’s Exact test for continuous and categorical variables, respectively
  2. aMean (STD, N) for continuous variables
  3. bNumber, N(%)for categorical variables